Post by Tega Eduwa
(Accredited)Applied Biomedical Science Graduate(Hons), Registered HCPC Biomedical Scientist & MSc Biotechnology Graduate
Artificial Intelligence is rapidly transforming the clinical trial landscape, helping address some of the biggest challenges in drug development. Recent developments show AI is being used to improve patient recruitment, optimise trial protocols, enhance participant retention, and support real time trial monitoring. Researchers are increasingly leveraging electronic health records and predictive analytics to identify eligible participants faster and reduce delays in study enrolment. Recent initiatives are also exploring AI powered monitoring systems that could shorten clinical trial timelines and accelerate the delivery of new therapies to patients. (https://lnkd.in/eucmfkiU) As a Biomedical Scientist with a strong interest in biotechnology and clinical research, I find it exciting to see how AI is being integrated alongside human expertise to make clinical trials more efficient, data driven, and patient centred. The future of clinical research will not be AI versus humans. It will be AI working alongside researchers, clinicians, and trial teams to improve outcomes and bring innovative treatments to patients faster. #ClinicalTrials #ArtificialIntelligence #ClinicalResearch #Biotechnology #DigitalHealth